Frank Milton Balis

9PUBLICATIONS
58CO-AUTHORS
GlycoconjugatesMolecular targetsPharmacogenomicsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 23, 2026
Circulating free and low-density lipoprotein-bound GD2 can compete in vitro with neuroblastoma cells for binding therapeutic anti-GD2 antibodies.

|May 26, 2026
A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

|Feb 11, 2025
New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis.

Frank M Balis, Elizabeth Rieger, Nancy J Bunin

|Jun 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane

|Sep 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.

Purnima Singh, Disheet A Shah, Mariam Jouni

|Oct 16, 2019
The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma.

Frank Milton Balis, Christine Maria Busch, Ami Vijay Desai

Pageof 2

Frequent Collaborators

2 joint publications

Smita Bhatia

1 joint publications

Suzanne P MacFarland

1 joint publications

Lea F Surrey

1 joint publications

Jennifer M Kalish